picolinic acid has been researched along with Amentia in 3 studies
picolinic acid: iron-chelating agent that inhibits DNA synthesis; may interfere with iron-dependent production of stable free organic radical which is essential for ribonucleotide reductase formation of deoxyribonucleotides; RN given refers to parent cpd; structure in Merck Index, 9th ed, #7206
picolinic acid : A pyridinemonocarboxylic acid in which the carboxy group is located at position 2. It is an intermediate in the metabolism of tryptophan.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Akhtar, A | 1 |
| Dhaliwal, J | 1 |
| Saroj, P | 1 |
| Uniyal, A | 1 |
| Bishnoi, M | 1 |
| Sah, SP | 1 |
| McCleery, J | 1 |
| Abraham, RP | 1 |
| Denton, DA | 1 |
| Rutjes, AW | 1 |
| Chong, LY | 1 |
| Al-Assaf, AS | 1 |
| Griffith, DJ | 1 |
| Rafeeq, S | 1 |
| Yaman, H | 1 |
| Malik, MA | 1 |
| Di Nisio, M | 1 |
| Martínez, G | 1 |
| Vernooij, RW | 1 |
| Tabet, N | 1 |
| Krikorian, R | 1 |
| Eliassen, JC | 1 |
| Boespflug, EL | 1 |
| Nash, TA | 1 |
| Shidler, MD | 1 |
1 review available for picolinic acid and Amentia
| Article | Year |
|---|---|
Vitamin and mineral supplementation for preventing dementia or delaying cognitive decline in people with mild cognitive impairment.
Topics: Aged; Aged, 80 and over; alpha-Tocopherol; Ascorbic Acid; Cognition; Cognition Disorders; Dementia; | 2018 |
1 trial available for picolinic acid and Amentia
| Article | Year |
|---|---|
Improved cognitive-cerebral function in older adults with chromium supplementation.
Topics: Aged; Blood Glucose; Brain; Chromium; Cognition; Dementia; Depression; Dietary Supplements; Double-B | 2010 |
1 other study available for picolinic acid and Amentia
| Article | Year |
|---|---|
Chromium picolinate attenuates cognitive deficit in ICV-STZ rat paradigm of sporadic Alzheimer's-like dementia via targeting neuroinflammatory and IRS-1/PI3K/AKT/GSK-3β pathway.
Topics: Alzheimer Disease; Animals; Cognitive Dysfunction; Dementia; Disease Models, Animal; Dose-Response R | 2020 |